Dostinex (cabergoline) tablets 0.5 mg. №8


Manufacturer: Italy



Inhibition of physiological postpartum lactation immediately after delivery or suppression of lactation established in the following cases: after delivery, if the mother has decided not to breastfeed the baby, or when breast-feeding is contraindicated to the mother or child for medical reasons; after the birth of a dead fetus or abortion. Disorders associated with hyperprolactinemia, including amenorrhea, oligomenorrhea, anovulation, and galactorrhea. Treatment of patients with prolactin-secreting pituitary adenoma (micro-and macroprolactinomas), idiopathic hyperprolactinemia or “empty” Turkish saddle syndrome with concomitant hyperprolactinemia, which are the main pathological conditions that cause the above-mentioned clinical manifestations.